Summary:
Study evaluating the safety and therapeutic effects of an investigational cholesterol-lowering drug as compared to an FDA-approved cholesterol-lowering drug.
Qualified Participants Must:
Be male or female, 18-65 years of age
Have a cholesterol level greater than 200mg/dL